Immunological self/nonself discrimination

Immunologic Research

Volumn 19, Issue 1, 1999, Pages 65-87

  Mannie, Mark D ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Adaptive immunity; Antigen presentation; Autoimmunity; Immunoregulation; MHC; T cell receptor; T lymphocytes

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; AUTOIMMUNITY; CELL INTERACTION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MODEL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0033061931     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02786477     Document Type: Review

References (154)

1. Van Parijs L, Abbas AK: Homeostasis and self-tolerance in the immune system: Turning lymphocytes off [Review] [50 refs]. Science 1998;280:243-248.
2. King C, Sarvetnick N: Organ-specific autoimmunity [Review] [75 refs]. Curr Opinion Immunol 1997;9:863-871.
3. Del Prete G: The concept of type-1 and type-2 helper T cells and their cytokines in humans [Review] [120 refs]. Intern Rev Immunol 1998;16:427-455.
4. Romagnani S, Parronchi P, D'Elios MM, Romagnani P, Annunziato F, Piccinni MP, et al.: An update on human Th1 and Th2 cells [Review] [30 refs]. Intern Arch Allergy Immunol 1997;113:153-156.
5. Adorini L, Trembleau S: Immune deviation towards Th2 inhibits Th1-mediated autoimmune diabetes [Review] [58 refs]. Biochem Soc Trans 1997;25:625-629.
6. Shaw AS, Dustin ML: Making the T cell receptor go the distance: A topological view of T cell activation [Review] [58 refs]. Immunity 1997;6:361-369.
7. Marks MS: Protein sorting within the MHC class II antigen-processing pathway [Review] [124 refs]. Immunol Res 1998;17:141-154.
8. Whitton JL: An overview of antigen presentation and its central role in the immune response [Review] [24 refs]. Curr Top Microbiol Immunol 1998;232:1-13.
9. Engering A, Lefkovits I, Pieters J: Analysis of subcellular organelles involved in major histocompatibility complex (MHC) class II-restricted antigen presentation by electrophoresis [Review] [56 refs]. Electrophoresis 1997;18:2523-2530.
10. Grewal IS, Flavell RA: The role of CD40 ligand in costimulation and T-cell activation [Review] [100 refs]. Immunol Rev 1996;153:85-106.
11. Grewal IS, Foellmer HG, Grewal KD, Xu J, Hardardottir F, Baron JL, et al.: Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 1996;273:1864-1867.
12. Guo Y, Wu Y, Shinde S, Sy MS, Aruffo A, Liu Y: Identification of a costimulatory molecule rapidly induced by CD40L as CD44H. J Exp Med 1996;184:955-961.
13. Shinde S, Wu Y, Guo Y, Niu Q, Xu J, Grewal IS, Flavell R, Liu Y: CD40L is important for induction of, but not response to, costimulatory activity. ICAM-1 as the second costimulatory molecule rapidly up-regulated by CD40L. J Immunol 1996;157:2764-2768.
14. Yang Y, Wilson JM: CD40 ligand-dependent T cell activation: Requirement of B7-CD28 signaling through CD40. Science 1996;273:1862-1864.
15. Goldstein MD, Debenedette MA. Hollenbaugh D, Watts TH: Induction of costimulatory molecules B7-1 and B7-2 in murine B cells. the CBA/N mouse reveals a role for Bruton's tyrosine kinase in CD40-mediated B7 induction. Mol Immunol 1996;33:541-552.
16. Mackey MF, Barth RJ Jr, Noelle RJ: The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells [Review] [105 refs]. J Leuk Biol 1998;63:418-428.
17. Lechler R, Marelli-Berg FM: Mechanisms of peripheral T-cell tolerance [Review] [33 refs]. J Viral Hepatitis 1997;4 Suppl 2:1-5.
18. Lu P, Wang YL, Linsley PS: Regulation of self-tolerance by CD80/CD86 interactions [Review] [34 refs]. Curr Opinion Immunol 1997;9:858-862.
19. Schweitzer AN, Sharpe AH: The complexity of the B7-CD28/CTLA-4 costimulatory pathway [Review] [48 refs]. Agents & Actions Suppl. 1998:49:33-43.
20. Tivol EA, Schweitzer AN, Sharpe AH: Costimulation and autoimmunity [Review] [66 refs]. Curr Opinion Immunol 1996;8:822-830.
21. Gill RG, Coulombe M, Lafferty KJ: Pancreatic islet allograft immunity and tolerance: The two-signal hypothesis revisited [Review] [94 refs]. Immunol Rev 1996;149:75-96.
22. Schultze J, Nadler LM, Gribben JG: B7-mediated costimulation and the immune response [Review] [107 refs]. Blood Reviews 1996;10:111-127.
23. Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system of T cell costimulation [Review] [117 refs]. Annu Rev Immunol 1996;14:233-258.
24. Kisielow P, Miazek A: Thymic selection and tolerance [Review] [34 refs]. Transplant Proc 1996;28:3429-3430.
25. Teh HS, Motyka B, Teh SJ: Influence of the affinity of selecting ligands on T cell positive and negative selection and the functional maturity of the positively selected T cells [Review] [52 refs]. Crit Rev Immunol 1997;17:399-410.
26. Bevan MJ: In thymic selection, peptide diversity gives and takes away [Review] [16 refs]. Immunity 1997;7:175-178.
27. Fowlkes BJ, Schweighoffer E: Positive selection of T cells [Review] [54 refs]. Curr Opinion Immunol 1995;7:188-195.
28. Kalwy S, Marty MC, Bausero P, Pessac B: Myelin basic protein-related proteins in mouse brain and immune tissues. J Neurochem 1998;70:435-438.
29. Kuramoto H, Hozumi I, Inuzuka T, Sato S: Occurrence of myelin-associated glycoprotein [MAG)-like immunoreactivity in some nervous, endocrine, and immune-related cells of the rat. An immunohistochemical study. Mol Chem Neuropathol 1997;31:85-94.
30. Kojima K, Reindl M, Lassmann H, Wekerle H, Linington C: The thymus and self-tolerance: Co-existence of encephalitogenic S100 beta-specific T cells and their nominal autoantigen in the normal adult rat thymus. Intern Immunol 1997;9:897-904.
31. Pribyl TM, Campagnoni CW, Kampf K, Kashima T, Handley VW, McMahon J, et al.: Expression of the myelin proteolipid protein gene in the human fetal thymus. J Neuroimmunol 1996;67:125-130.
32. Fritz RB, Kalvakolanu I: Thymic expression of the golli-myelin basic protein gene in the SJL/J mouse. J Neuroimmunol 1995;57:93-99.
33. Pribyl TM, Campagnoni CW, Kampf K, Kashima T, Handley VW, McMahon J, et al.: The human myelin basic protein gene is included within a 179-kilobase transcription unit: Expression in the immune and central nervous systems. Proc Natl Acad Sci USA 1993;90:10,695-10,699.
34. Mathisen PM, Pease S, Garvey J, Hood L, Readhead C: Identification of an embryonic isoform of myelin basic protein that is expressed widely in the mouse embryo. Proc Natl Acad Sci USA 1993;90:10,125-10,129.
35. Castro JE, Listman JA, Jacobson BA, Wang Y, Lopez PA, Ju S, et al.: Fas modulation of apoptosis during negative selection of thymocytes. Immunity 1996;5:617-627.
36. Noda S, Kosugi A, Saitoh S, Narumiya S, Hamaoka T: Protection from anti-TCR/CD3-induced apoptosis in immature thymocytes by a signal through thymic shared antigen-1/stem cell antigen-2. J Exp Med 1996;183:2355-2360.
37. von Boehmer H: Thymic selection: A matter of life and death. Immunol Today 1992;13:454-458.
38. Janeway CA Jr: Thymic selection: Two pathways to life and two to death [Review] [47 refs]. Immunity 1994;1:3-6.
39. Robey E, Fowlkes BJ: Selective events in T cell development [Review] [120 refs]. Annu Rev Immunol 1994;12:675-705.
40. Wang R, Nelson A, Kimachi K, Grey HM, Farr AG: The role of peptides in thymic positive selection of class II major histocompatibility complex-restricted T cells. Proc Natl Acad Sci USA 1998;95:3804-3809.
41. Ignatowicz L, Rees W, Pacholczyk R, Ignatowicz H, Kushnir E, Kappler J, et al.: T cells can be activated by peptides that are unrelated in sequence to their selecting peptide. Immunity 1997;7:179-186.
42. Surh CD, Lee DS, Fung-Leung WP, Karlsson L, Sprent J: Thymic selection by a single MHC/peptide ligand produces a semidiverse repertoire of CD4+ T cells. Immunity 1997;7:209-219.
43. Hu Q, Bazemore Walker CR, Girao C, Opferman JT, Sun J, Shabanowitz J, et al.: Specific recognition of thymic self-peptides induces the positive selection of cytotoxic T lymphocytes. Immunity 1997;7:221-231.
44. Hogquist KA, Tomlinson AJ, Kieper WC, McGargill MA, Hart MC, Naylor S, et al.: Identification of a naturally occurring ligand for thymic positive selection. Immunity 1997;6:389-399.
45. Barnden MJ, Heath WR, Rodda S, Carbone, FR: Peptide antagonists that promote positive selection are inefficient at T cell activation and thymocyte deletion. Eur J Immunol 1994;24:2452-2456.
46. Girao C, Hu Q, Sun J, Ashton-Rickardt PG: Limits to the differential avidity model of T cell selection in the thymus. J Immunol 1997;159:4205-4211.
47. Jameson SC, Hogquist KA, Bevan MJ: Positive selection of thymocytes. Annu Rev Immunol 1995;13:93-126.
48. Hogquist KA, Bevan MJ: The nature of the peptide/MHC ligand involved in positive selection. Sem Immunol 1996;8:63-68.
49. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone, FR: T cell receptor antagonist peptides induce positive selection. Cell 1994;76:17-27.
50. Pawlowski TJ, Singleton MD, Loh DY, Berg R, Staerz UD: Permissive recognition during positive selection. Eur J Immunol 1996;26:851-857.
51. Jameson SC, Hogquist KA, Bevan MJ: Specificity and flexibility in thymic selection. Nature 1994;369:750-752.
52. Barnden MJ, Heath WR, Carbone FR: Down-modulation of CD8 beta-chain in response to an altered peptide ligand enables developing thymocytes to escape negative selection. Cell Immunol 1997;175:111-119.
53. Jameson SC, Bevan MJ: T-cell selection [In Process Citation]. Curr Opinion Immunol 1998;10:214-219.
54. Lafferty KJ, Prowse SJ, Simeonovic CJ, Warren HS: Immunobiology of tissue transplantation: A return to the passenger leukocyte concept [Review] [116 refs]. Annu Rev Immunol 1983;1:143-173.
55. Janeway CA Jr: The immune system evolved to discriminate infectious nonself from noninfectious self [Review] [38 refs]. Immunol Today 1992;13:11-16.
56. Janeway CA Jr, Goodnow CC, Medzhitov R: Danger - Pathogen on the premises: Immunological tolerance [Review] [20 refs]. Curr Biol 1996;6:519-522.
57. Medzhitov R, Janeway CA Jr: Innate immunity: Impact on the adaptive immune response [Review] [40 refs]. Curr Opinion Immunol 1997;9:4-9.
58. Medzhitov R, Janeway CA Jr: Innate immunity: the virtues of a nonclonal system of recognition [Review] [17 refs]. Cell 1997;91:295-298.
59. Fenton RG, Longo DL: Danger vs tolerance: paradigms for future studies of tumor-specific cytotoxic T lymphocytes [editorial; comment] [Review] [28 refs]. J Natl Can Inst 1997;89:272-275.
60. Matzinger P: Tolerance, danger, and the extended family [Review] [157 refs]. Annu Rev Immunol 1994;12:991-1045.
61. Sousa CR, Hieny S, Scharton-Kersten T, Jankovic D, Charest H, Germain RN, et al.: In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas [see comments]. J Exp Med 1997;186:1819-1829.
62. Mannie MD: Immune discrimination of self and nonself: A unified theory for the induction of self tolerance among thymocytes and mature peripheral T cells. Med Hypotheses 1993;40:105-112.
63. Bretscher P, Cohn M: A theory of self-nonself discrimination. Science 1970;169:1042-1049.
64. Mueller DL, Jenkins MK, Schwartz RH: Clonal expansion vs functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989;7:445-480.
65. Purbhoo MA, Sewell AK, Klenerman P, Goulder PJ, Hilyard KL, Bell JI, et al.: Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascade. Proc Natl Acad Sci USA 1998;95:4527-4532.
66. Totsuka M, Furukawa S, Sato E, Ametani A, Kaminogawa S: Antigen-specific inhibition of CD4+ T-cell responses to beta-lactoglobulin by its single amino acid-substituted mutant form through T-cell receptor antagonism. Cytotechnology 1997;25:115-126.
67. Viola A, Linkert S, Lanzavecchia A: A T cell receptor (TCR) antagonist competitively inhibits serial TCR triggering by low-affinity ligands, but does not affect triggering by high-affinity anti-CD3 antibodies. Eur J Immunol 1997;27:3080-3083.
68. La Face DM, Couture C, Anderson K, Shih G, Alexander J, Sette A, et al.: Differential T cell signaling induced by antagonist peptide-MHC complexes and the associated phenotypic responses. J Immunol 1997;158:2057-2064.
69. Liu C, Goldstein J, Graziano RF, He J, O'Shea JK, Deo Y, et al.: F(c)gammaRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonist T cell epitopes. J Clin Invest 1996;98:2001-2007.
70. Kuchroo VK, Greer JM, Kaul D, Ishioka G, Franco A, Sette A, et al.: A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire. J Immunol 1994;153:3326-3336.
71. Racioppi L, Ronchese F, Matis LA, Germain RN: Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J Exp Med 1993;177:1047-1060.
72. Snoke K, Alexander J, Franco A, Smith L, Brawley JV, Concannon P, et al.: The inhibition of different T cell lines specific for the same antigen with TCR antagonist peptides. J Immunol 1993;151:6815-6821.
73. Mannie MD, Rosser JM, White GA: Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4. Evidence for the integration of efficacious and nonefficacious signals during T cell antigen recognition. J Immunol 1995;154:2642-2654.
74. Rogers PR, Grey HM, Croft M: Modulation of naive CD4 T cell activation with altered peptide ligands: The nature of the peptide and presentation in the context of costimulation are critical for a sustained response. J Immunol 1998;160:3698-3704.
75. Daniel C, Grakoui A, Allen PM: Inhibition of an in vitro CD4+ T cell allo-response using altered peptide ligands. J Immunol 1998;160:3244-3250.
76. Sloan-Lancaster J, Allen PM: Altered peptide ligand-induced partial T cell activation: Molecular mechanisms and role in T cell biology. Annu Rev Immunol 1996;14:1-27.
77. Hollsberg P, Weber WE, Dangond F, Batra V, Sette A, Hafler DA: Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand. Proc Natl Acad Sci USA 1995;92:4036-4040.
78. Madrenas J, Germain RN: Variant TCR ligands: New insights into the molecular basis of antigen-dependent signal transduction and T-cell activation. Semin Immunol 1996;8:83-101.
79. Madrenas J, Chau LA, Smith J, Bluestone JA, Germain RN: The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands. J Exp Med 1997;185:219-229.
80. Reis e Sousa C, Levine EH, Germain RN: Partial signaling by CD8+ T cells in response to antagonist ligands. J Exp Med 1996;184:149-157.
81. Madrenas J, Wange RL, Wang JL, Isakov N, Samelson LE, Germain RN: Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists [see comments]. Science 1995;267:515-518.
82. Racioppi L, Germain RN: Modified T-cell receptor ligands: Moving beyond a strict occupancy model for T-cell activation by antigen. Chem Immunol 1995;60:79-99.
83. Evavold BD, Allen PM: Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 1991;252:1308-1310.
84. Evavold BD, Sloan-Lancaster J, Hsu BL, Allen PM: Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J Immunol 1993;150:3131-3140.
85. Germain RN: T-cell signaling: the importance of receptor clustering [Review] [29 refs]. Curr Biol 1997;7:R640-644.
86. Dustin ML, Bromley SK, Kan Z, Peterson DA, Unanue ER: Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. Proc Natl Acad Sci USA 1997;94:3909-3913.
87. Washington EA, Kimpton WG, Holder JE, Cahill RN: Role of the thymus in the generation of skin-homing alpha beta and gamma delta virgin T cells. Eur J Immunol 1995;25:723-727.
88. Kurts C, Heath WR, Carbone FR, Allison J, Miller JF, Kosaka H: Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med 1996;184:923-930.
89. Forster I, Lieberam I: Peripheral tolerance of CD4 T cells following local activation in adolescent mice. Eur J Immunol 1996;26:3194-3202.
90. Kimpton WG, Washington EA, Cahill RN: Virgin alpha beta and gamma delta T cells recirculate extensively through peripheral tissues and skin during normal development of the fetal immune system. Intern Immunol 1995;7:1567-1577.
91. Kroemer G, Cuende E, Martinez C: Compartmentalization of the peripheral immune system. Adv Immunol 1993;53:157-216.
92. Mannie MD: The post-activation refractory phase: A mechanism to measure antigenic complexity and ensure self-tolerance among mature peripheral T lymphocytes. Med Hypotheses 1996;47:467-470.
93. Kaufman M, Andris F, Leo O: A model for antigen-induced T cell unresponsiveness based on autophosphorylative protein tyrosine kinase activity. Intern Immunol 1996;8:613-624.
94. Willems F, Andris F, Xu D, Abramowicz D, Wissing M, Goldman M, et al.: The induction of human T cell unresponsiveness by soluble anti-CD3 mAb requires T cell activation. Intern Immunol 1995;7:1593-1598.
95. Dubois PM, Andris F, Shapiro RA, Gilliland LK, Kaufman M, Urbain J, et al.: T cell long-term hypo-responsiveness follows antigen receptor engagement and results from defective signal transduction. Eur J Immunol 1994;24:348-354.
96. Andris F, Van Mechelen M, De Mattia F, Baus E, Urbain J, Leo O: Induction of T cell unresponsiveness by anti-CD3 antibodies occurs independently of co-stimulatory functions. Eur J Immunol 1996;26:1187-1195.
97. Andris F, Van Mechelen M, Legrand N, Dubois PM, Kaufman M, Urbain J, et al.: Induction of long-term but reversible unresponsiveness after activation of murine T cell hybridomas. Intern Immunol 1991;3:609-616.
98. Pantalco G, Olive D, Poggi A, Pozzan T, Moretta L, Moretta A: Antibody-induced modulation of the CD3/T cell receptor complex causes T cell refractoriness by inhibiting the early metabolic steps involved in T cell activation. J Exp Med 1987;166:619-624.
99. Cai Z, Kishimoto H, Brunmark A, Jackson MR, Peterson PA, Sprent J: Requirements for peptide-induced T cell receptor downregulation on naive CD8+ T cells. J Exp Med 1997;185:641-651.
100. Mannie MD, White GA, Lake KR, Nardella JP, Marinakis CA, McConnell TJ: T-helper lymphocytes specific for myelin basic protein: Low-density activation prolongs a postactivation refractory phase marked by decreased pathogenicity and enhanced sensitivity to anergy. Cell Immunol 1996;172:108-117.
101. Kramer S, Schimpl A, Hunig T: Immunopathology of interleukin (IL) 2-deficient mice: Thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J Exp Med 1995;182:1769-1776.
102. Simpson SJ, Mizoguchi E, Allen D, Bhan AK, Terhorst C: Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis. Eur J Immunol 1995;25:2618-2625.
103. Heuer J, Kolsch E: Functional studies on the role of I-A molecules expressed by the antigen-specific T suppressor cell clone HFI. J Immunol 1985;134:4031-4034.
104. Reske-Kunz AB, Reske K, Rude E: Cloned murine Ia+ BK-BI-2.6.C6 T cells function as accessory cells presenting protein antigens to long-term-cultured antigen-specific T cell lines. J Immunol 1986;136:2033-2040.
105. Ben-Nun A, Strauss W, Leeman SA, Cohn LE, Murre C, Duby A, et al.: An Ia-positive mouse T-cell clone is functional in presenting antigen to other T cells. Immunogenetics 1985;22:123-130.
106. Graf L, Koch N, Schirrmacher V: Expression of Ia antigens in a murine T-lymphoma variant. Mol Immunol 1985;22:1371-1377.
107. Gautam SC, Matriano JA, Chikkala NF, Edinger MG, Tubbs RR: L3T4 (CD4+) cells that mediate contact sensitivity to trinitrochlorobenzene express I-A determinants. Cell Immunol 1991;135:27-41.
108. Reske K, Mohle U, Sun D, Wekerle H: Synthesis and cell surface display of class II determinants by long-term propagated rat T line cells. Eur J Immunol 1987;17:909-914.
109. Kira J, Itoyama Y, Goto I: Generation of CD4+ blastoid T cells showing marked upregulation of CD4, class I and II MHC, and IL2 receptor molecules is required for the expression of potent encephalitogenicity. Cell Immunol 1989;123:264-275.
110. Bevan DJ, Chisholm PM: Co-expression of CD4 and CD8 molecules and de novo expression of MHC class II antigens on activated rat T cells. Immunol 1986;59:621-625.
111. Reizis B, Schramm C, Cohen IR, Mor F: Expression of major histocompatibility complex class II molecules in rat T cells. Eur J Immunol 1994;24:2796-2802.
112. Yu DT, McCune JM, Fu SM, Winchester RJ, Kunkel HG: Two types of Ia-positive T cells. Synthesis and exchange of Ia antigens. J Exp Med 1980;152:89s-98s.
113. Yu DT, Winchester RJ, Fu SM, Gibofsky A, Ko HS, Kunkel HG: Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization. J Exp Med 1980;151:91-100.
114. Evans RL, Faldetta TJ, Humphreys RE, Pratt DM, Yunis EJ, Schlossman SF: Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens. J Exp Med 1978;148:1440-1445.
115. Reinherz EL, Kung PC, Pesando JM, Ritz J, Goldstein G, Schlossman SF: Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression. J Exp Med 1979;150:1472-1482.
116. Ko HS, Fu SM, Winchester RJ, Yu DT, Kunkel HG: Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells. J Exp Med 1979;150:246-255.
117. Lamb JR, Skidmore BJ, Green N, Chiller JM, Feldman M: Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J Exp Med 1983;157:1434.
118. Lamb JR, Feldmann M: Essential requirement for major histocompatibility complex recognition in T cell tolerance induction. Nature 1984;308:72.
119. LaSalle JM, Tolentino PJ, Freeman GJ, Nadler LM, Hafler DA: Early signaling defects in human T cells anergized by T cell presentation of autoantigen. J Exp Med 1992;176:177-186.
120. LaSalle JM, Toneguzzo F, Saadeh M, Golan DE, Taber R, Hafler D: T cell presentation of antigen requires cell-to-cell contact for proliferation and anergy induction: Differential MHC requirements for superantigen and autoantigen. J Immunol 1993;151:649-657.
121. LaSalle JM, Hafler DA: T cell anergy. FASEB J 1994;8:601-608.
122. Celis E, Saibara T: Binding of T cell receptor to major histocompatibility complex class II peptide complexes at the single-cell level results in the induction of antigen unresponsiveness (anergy). Eur J Immunol 1992;22:3127-3134.
123. + T cells by activated T cell stimulators. Eur J Immunol 1994;24:2457-2461.
124. Bettens F, Fret E, Frutig K, Mauri D, Pichler WJ, Wyss-Coray T: Noncytotoxic human CD4+ T-cell clones presenting and simultaneously responding to an antigen die of apoptosis. Cell Immunol 1995;161:72-78.
125. Pichler WJ, Wyss-Coray T: T cells as antigen-presenting cells. Immunol Today 1994;15:312-315.
126. Mannie MD, Rendall SK, Arnold PY, Nardella JP, White GA: Anergy-associated T cell antigen presentation. A mechanism of infectious tolerance in experimental autoimmune encephalomyelitis. J Immunol 1996;157:1062-1070.
127. Mauri D, Wyss-Coray T, Gallati H. Pichler WJ: Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules. J Immunol 1995;155:118-127.
128. Lorber MI, Loken MR, Stall AM, Fitch FW: I-A antigens on cloned alloreactive murine T lymphocytes are acquired passively. J Immunol 1982;128:2798-2803.
129. Arnold PY, Davidian DK, Mannie MD: Antigen presentation by T cells: T cell receptor ligation promotes antigen acquisition from professional antigen-presenting cells. Eur J Immunol 1997;27:3198-3205.
130. Raposo G, Nijman HW, Stoorvogel W, Leijendekker R, Harding CV, Melief CJM, et al.: B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996;183:1161-1172.
131. Mannie MD, White GA, Nardella JP, Davidian DK, Arnold PY: Partial agonism elicits an enduring phase of T cell-mediated antigen presentation. Cell Immunol 1998;186:83-93.
132. Mannie MD, Nardella JP, White GA, Arnold PY, Davidian DK: Class II MHC/peptide complexes on T cell antigen-presenting cells: Agonistic antigen recognition inhibits subsequent antigen presentation. Cell Immunol 1998;186:111-120.
133. Mannie MD: Do holes in the T-cell repertoire have a center-surround regulatory structure? A rationale for the bifurcation of the Th1 and Th2 pathways of differentiation. Med Hypotheses 1997;48:261-265.
134. Parish CR, O'Neill ER: Dependence of the adaptive immune response on innate immunity: Some questions answered but new paradoxes emerge. Immunology & Cell Biology 1997;75:523-527.
135. Cook SD, Rohowsky-Kochan C, Bansil S, Dowling PC: Evidence for multiple sclerosis as an infectious disease. Acta Neurol Scand Suppl 1995;161:34-42.
136. Kurtzke JF: Epidemiologic evidence for multiple sclerosis as an infection [published erratum appears in Clin Microbiol Rev 1994 Jan;7(1):141]. Clin Microbiol Rev 1993;6:382-427.
137. Gautam AM, Liblau R, Chelvanayagam G, Steinman L, Boston T: A viral peptide with limited homology to a self peptide can induce clinical signs of experimental autoimmune encephalomyelitis [in process citation]. J Immunol 1998;161:60-64.
138. Ewing C, Bernard CC: Insights into the aetiology and pathogenesis of multiple sclerosis. Immunol Cell Biol 1998:76:47-54.
139. Bhardwaj V, Kumar V, Geysen HM, Sercarz EE: Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. Implications for thymic education and autoimmunity. J Immunol 1993;151:5000-5010.
140. Weissert R, Svenningsson A, Lobell A, de Graaf KL Andersson R, Olsson T: Molecular and genetic requirements for preferential recruitment of TCRBV8S2+ T cells in Lewis rat experimental autoimmune encephalomyelitis. J Immunol 1998;160:681-690.
141. Sun D, Le J, Coleclough C: Diverse T cell receptor beta chain usage by rat encephalitogenic T cells reactive to residues 68-88 of myelin basic protein. Eur J Immunol 1993;23:494-498.
142. Sun D, Shah R, Coleclough C: Repertoire of rat MBP-reactive T cells: DNA sequencing analysis further demonstrates the clonal heterogeneity of rat T cells reactive against encephalitogenic epitopes. Cell Immunol 1994;156:389-401.
143. Sun D, Hu XZ, Le J, Swanborg RH: Characterization of brain-isolated rat encephalitogenic T cell lines. Eur J Immunol 1994;24:1359-1364.
144. Sun D, Coleclough C, Hu XZ: Heterogencity of rat encephalitogenie T cells elicited by variants of the myelin basic protein (68-86) peptide. Eur J Immunol 1995;25:1687-1692.
145. Gold R, Giegerich G, Hartung HP, Toyka KV: T-cell receptor (TCR) usage in Lewis rat experimental autoimmune encephalomyelitis: TCR beta-chain-variable-region V beta 8.2-positive T cells are not essential for induction and course of disease. Proc Natl Acad Sci USA 1995;92:5850-5854.
146. Johnson BD, Nardella JP, McConnell TJ, Mannie MD: Acquired resistance to experimental autoimmune encephalomyelitis is independent of V beta usage. Cell Immunol 1997;179:55-65.
147. Buenafe AC, Vainiene M, Celnik B, Vandenbark AA, Offner H: Analysis of V beta 8-CDR3 sequences derived from central nervous system of Lewis rats with experimental autoimmune encephalomyelitis. J Immunol 1994;153:386-394.
148. Chluba J, Steeg C, Becker A, Wekerle H, Epplen JT: T cell receptor beta chain usage in myelin basic protein-specific rat T lymphocytes. Eur J Immunol 1989;19:279-284.
149. Tsuchida M, Matsumoto Y, Hirahara H, Hanawa H, Tomiyama K, Abo T: Preferential distribution of V beta 8.2-positive T cells in the central nervous system of rats with myelin basic protein-induced autoimmune encephalomyelitis. Eur J Immunol 1993;23:2399-2406.
150. Offner H, Bucnafe AC, Vainiene M, Celnik B, Weinberg AD, Gold DP, et al.: Where, when, and how to detect biased expression of disease-relevant V beta genes in rats with experimental autoimmune encephalomyelitis. J Immunol 1993;151:506-517.
151. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S: Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice [see comments]. Cell 1993;75:274-282.
152. Horak I: Immunodeficiency in IL2-knockout mice. Clin Immunol Immunopathol 1995;76:S172-173.
153. Elson CO, Sartor RB, Tennyson GS, Riddell RH: Experimental models of inflammatory bowel disease. Gastroenterology 1995;109:1344-1367.
154. Tsubata R, Tsubata T, Hiai H, Shinkura R, Matsumura R, Sumida T, et al.: Autoimmune disease of exocrine organs in immunodeficient alymphoplasia mice: a spontaneous model for Sjogren"s syndrome. Eur J Immunol 1996;26:2742-2748.